GE Healthcare wins oligo fit out in China

By Flora Southey contact

- Last updated on GMT


Related tags: Dna

RiBoBio has chosen GE Healthcare to equip its oligonucleotide API facility in Guangzhou, China.

Under the agreement, GE Healthcare Life Sciences will install its laser-based, cell imagine technology – IN Cell Analyzer 6500HS – and its ÄKTA OligoProcess platform, used to synthesise kilogram quantities of oligonucleotides.

Oligonucleotides – chemically synthesised short nucleic acid polymers designed to fuse with DNA or ribonucleic acid (RNA) sequences – are designed to treat infectious, and genetic diseases, as well as some cancers.

According to RiBoBio, the firms aim to “jointly build Asia’s largest oligonucleotide drug development and manufacturing facility in China.”

A RiBoBio spokesperson told us the site will not uniquely target Chinese firms.

“RiBoBio will make oligonucleotide APIs ​[active pharmaceutical ingredients] to provide CDMO ​[contract development and manufacturing organisation] services for clients worldwide,” ​said the spokesperson.

The firm did not disclose the cost of the facility, but said it expects the site to be operational by the end of 2018.

US oligo boost

The US has shown an increased interest in oligo treatments, with recent facility expansions in central and north-east states.

In August, 2016, Agilent announced​ plans for a nucleic acid API manufacturing plant in Colorado, and in July this year, Nitto Denko Avecia said​ it would launch its expanded oligo API facility in Massachusetts.

GE Healthcare and CordenPharma also announced​ a strategic agreement for oligonucleotide development in July, under which GE Healthcare’s Dharmacon will offer early-phase, and CordenPharma later phase, services.  

Related news

Related products

show more

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us


View more